Announcements Trials

Browse Landscape

Phase

Phase 1 9 Phase 2 6 Phase 1/2 2 Phase 3 1 Phase 2/3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Nasopharyngeal Carcinoma 4 Rectal Neoplasms 2 Melanoma 2 Carcinoma, Hepatocellular 2 Uterine Cervical Neoplasms 1 Squamous Cell Non-small Cell Lung Cancer 1 Squamous Cell Carcinoma of Head and Neck 1 Skin Neoplasms 1 Recurrence 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Nasopharyngeal Neoplasms 1 Locally Advanced Low Rectal Adenocarcinoma 1 HER2+ Breast Cancer 1 Epstein-Barr Virus Infections 1 Diabetes Mellitus, Insulin-Dependent, 12 1 Colorectal Neoplasms, Hereditary Nonpolyposis 1 Colorectal Neoplasms 1

Interventions

Fluorouracil 131 Leucovorin 127 Oxaliplatin 93 Bevacizumab 86 Irinotecan 74 Capecitabine 63 Cetuximab 47 Folfox protocol 32 Panitumumab 18 regorafenib 16 trifluridine tipiracil drug combination 15 Drug Therapy 14 Chemotherapy, Adjuvant 13 IFL protocol 10 Floxuridine 10 Radiotherapy 9 Tegafur 7 Neoadjuvant Therapy 7 Levoleucovorin 7 Laparoscopy 7 Aspirin 7 pembrolizumab 6 atezolizumab 6 Trifluridine 6 Celecoxib 6 XELOX 5 Mitomycin 5 Colonoscopy 5 tipiracil 4 sintilimab 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Colorectal Neoplasms × spartalizumab × Clear all

NCT06794086 2025-05-13

SPARKLE-L

Sixth Affiliated Hospital, Sun Yat-sen University

Phase 3 Recruiting

Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡